IDEX Corporation Reports Record Sales and Orders for Q3 2025

By Greg Peters • Wednesday, October 29 15:42 • Permanent Link

IDEX Corporation (NYSE: IEX) has reported its financial results for the third quarter of 2025, highlighting several key metrics that demonstrate the company's performance compared to the prior year period.

Record Sales: The company reported record sales of $879 million, representing a 10% increase on a reported basis and a 5% increase organically compared to the prior year period.
Earnings Per Share (EPS): Reported diluted EPS of $1.70 increased by 8%, and adjusted diluted EPS of $2.03 increased by 7% compared to the same period last year.
Record Orders: Orders reached $880 million, marking a 13% increase on a reported basis and a 7% increase organically compared to the prior year period.
Share Repurchases: The company utilized $75 million for share repurchases in Q3 2025 and $175 million year-to-date, and increased the share repurchase authorization to $1 billion.
Full Year Outlook: The full-year 2025 outlook for GAAP diluted EPS was narrowed to $6.35 * $6.40, and adjusted diluted EPS was narrowed to $7.86 * $7.91, both within the prior guidance range.

The consolidated financial results for the third quarter of 2025 compared to the same period in the prior year showed significant increases in various metrics. The net sales increased by 10%, gross profit increased by 11%, and net income attributable to IDEX increased by 7.3%.

The company also provided segment financial results for the third quarter of 2025, highlighting the following changes: Health & Science Technologies: Net sales increased by 22% and adjusted EBITDA margin increased by 120 basis points. Fluid & Metering Technologies: Net sales increased by 5% and adjusted EBITDA margin increased by 90 basis points. * Fire & Safety/Diversified Products: Net sales decreased by 3%, and adjusted EBITDA margin decreased by 200 basis points.

The company's corporate costs included in consolidated adjusted EBITDA increased slightly from the same prior year period.

As a result of these announcements, the company's shares have moved -0.39% on the market, and are now trading at a price of $166.95. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.